JB BONUS CERTIFICATE - ROCHE GS Stock

Certificat

SAABJB

CH1252039644

Real-time Bid/Ask 03:19:36 2024-07-17 am EDT
277.75 CHF / 279.25 CHF +4.21% Intraday chart for JB BONUS CERTIFICATE - ROCHE GS
1 month+3.79%
3 months+16.91%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-16 267.2 +0.19%
24-07-15 266.8 +0.95%
24-07-12 264.2 +1.05%
24-07-11 261.5 +0.77%

Delayed Quote Swiss Exchange

Last update July 16, 2024 at 11:20 am EDT

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Bank Julius Bär
SAABJB
ISINCH1252039644
Date issued 2023-04-11
Strike 273.6 CHF
Maturity 2025-04-11 (269 Days)
Parity 1 : 1
Emission price 273.6 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 287.8 CHF
Lowest since issue 219.8 CHF
Spread 1.25 CHF
Spread %0.47%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
258.9 CHF
Average target price
274 CHF
Spread / Average Target
+5.83%
Consensus
  1. Stock Market
  2. Certificates
  3. SAABJB Certificat